Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Evaluation of an Expanded Disability Status Scale (EDSS) modeling strategy in multiple sclerosis.
EBV and vitamin D status in relapsing-remitting multiple sclerosis patients with a unique cytokine signature.
Recurrent Guillain-Barré syndrome presenting stereotypic manifestations, positive antiganglioside antibodies, and rapid recovery.
Advances in the management of MS symptoms: recently proposed clinical management algorithms.
Including a subject-paced trial may make the PASAT more acceptable for MS patients.
Clinical and MRI phenotype of children with MOG antibodies.
Decoding the substrate supply to human neuronal nitric oxide synthase.
Migraine Headaches And Pain With Neuropathic Characteristics: Comorbid Conditions In Patients With Multiple Sclerosis.
Review of the novelties presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (III).
Psychiatric diagnoses and cognitive impairment in pediatric multiple sclerosis.
Palliative treatment of chronic neurologic disorders.
Erratum: the neuroradiology journal 26: 143-150, 2013. Multiple sclerosis: identification of temporal changes in brain lesions with computer-assisted detection software.
Nogo-Receptor 1 Deficiency Has No Influence on Immune Cell Repertoire or Function during Experimental Autoimmune Encephalomyelitis.
Molecular and cellular analyses of HLA class II-associated susceptibility to autoimmune diseases in the Japanese population.
Maternal Neurofascin-Specific Autoantibodies Bind to Structures of the Fetal Nervous System during Pregnancy, but Have No Long Term Effect on Development in the Rat.
Do Patients With Multiple Sclerosis Show Different Daily Physical Activity Patterns From Healthy Individuals?
Feasibility and Findings from a Novel Working Memory fMRI Paradigm in Multiple Sclerosis.
Changes of statistical structural fluctuations unveils an early compacted degraded stage of PNS myelin.
New data confirm high efficacy of Gilenya® in achieving 'no evidence of disease activity (NEDA)' based on four key measures of MS
Cleavage and polyadenylation specificity factor 1 (CPSF1) regulates alternative splicing of interleukin 7 receptor (IL7R) exon 6.
Minocycline: Far beyond an antibiotic.
Symptomatic brain involvement as the initial manifestation of neuromyelitis optica.
Disease activity return after natalizumab cessation in multiple sclerosis.
Multiple sclerosis: Does low vitamin D level during pregnancy increase the risk of MS?
Neuroglial alterations in the zebrafish brain exposed to cadmium chloride.

Pages